DUPUYTREN LITERATURE: ECONOMIC IMPACT

These materials are available for nonprofit educational use. This repository is allowed by copyright disclaimer under title 17, Appendix E, section 107 of the United States Copyright Act. Under this statute, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. As defined, fair use specifically applies to this repository.

Medline Title Search (Dupuytren + (Economic or Cost or Resource)

Selected Publications

• Bainbridge C, Dahlin LB, Szczypa PP, Cappelleri JC, Guerin D, Gerber RA. (2012). “Current Trends in the Surgical Management of Dupuytren’s Disease in Europe: An Analysis of Patient Charts.” Eur Orthop Traumatol 3 (1): 31–41. (PDF)
• Brazzelli Miriam, Cruickshank Moira, Tassie Emma, McNamee Paul, Robertson Clare, Elders Andrew, Fraser Cynthia, Hernandez Rodolfo, Lawrie David, Ramsay Craig. (2015). “Collagenase Clostridium Histolyticum for the Treatment of Dupuytren’s Contracture: Systematic Review and Economic Evaluation.” Health Technology Assessment (Winchester, England) 19 (90): 1–202. (PDF)
• Chen Neal C, Shauver Melissa J, Chung Kevin C. (2010). “An Economic Analysis of Fasciectomy, Needle Aponeurotomy, and Collagenase Injection for Dupuytren’s Contracture.” The Journal of Hand Surgery 35 (10). The American Society for Surgery of the Hand: 43–44. (PDF)
• Chen NC, Shauver MJ, Chung KC. (2011). “ Cost-Effectiveness of Open Partial Fasciectomy, Needle Aponeurotomy, and Collagenase Injection for Dupuytren Contracture .” J Hand Surg Am 36 (11): 1826–1834 e32. http://www.ncbi.nlm.nih.gov/pubmed/21981831. (PDF)
• Dahlin LB, Bainbridge C, Szczypa PP, Cappelleri JC, Guerin D, Gerber RA. (2012). “Current Trends in the Surgical Management of Dupuytren’s Disease in Europe: The Surgeon’s Perspective.” Eur Orthop Traumatol 3 (1): 25–30. (PDF)
• Dahlin LB, Bainbridge C, Leclercq C, Gerber RA, Guerin D, Cappelleri JC, Szczypa PP, Dias J. (2013). “Dupuytren’s Disease Presentation, Referral Pathways and Resource Utilisation in Europe: Regional Analysis of a Surgeon Survey and Patient Chart Review.” International Journal of Clinical Practice. (PDF)
• De Salas-Cansado M, Cuadros M, Del Cerro M, Arandes JM. (2013). “Budget Impact Analysis in Spanish Patients with Dupuytren’s Contracture: Fasciectomy vs. Collagenase Clostridium Histolyticum.” Chirurgie de La Main 32 (2). Elsevier Masson SAS: 68–73. (PDF)
• Dritsaki Melina, Rivero-Arias Oliver, Gray Alastair, Ball Catherine, Nanchahal Jagdeep. (2018). “What Do We Know about Managing Dupuytren’s Disease Cost-Effectively?” BMC Musculoskeletal Disorders 19 (1). BMC Musculoskeletal Disorders: 34. (PDF)
• Dias J, Bainbridge C, Leclercq C, Gerber RA, Guerin D, Cappelleri JC, Szczypa PP, Dahlin LB. (2013). “Surgical Management of Dupuytren’s Contracture in Europe: Regional Analysis of a Surgeon Survey and Patient Chart Review.” International Journal of Clinical Practice.(PDF)
• Eckerdal David, Nivestam Axel, Dahlin Lars B. (2014). “Surgical Treatment of Dupuytren’s Disease – Outcome and Health Economy in Relation to Smoking and Diabetes.” BMC Musculoskeletal Disorders 15 (1). BMC Musculoskeletal Disorders: 117. (PDF)
• Macaulay Dendy, Ivanova Jasmina, Birnbaum Howard, Sorg Rachael, Skodny Paul. (2012). “Direct and Indirect Costs Associated with Dupuytren’s Contracture.” Journal of Medical Economics 15 (4): 664–71. (PDF)
• Maguire B, Makino K, Tilden D, Ballmer A, Hart S. (2014). “Health Care Resource Requirements and Costs During the Recovery Phase of Fasciectomy for the Treatment of Dupuytren’s Contracture: Clinician Survey.” Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research 17 (7): A773. (PDF)
• Maravic M, Landais P. (2005). “Dupuytren’s Disease in France–1831 to 2001–from Description to Economic Burden.” Journal of Hand Surgery (Edinburgh, Scotland) 30 (5): 484–87. (PDF)
• Maravic M, Lasbleiz S, Roulot E, Beaudreuil J. (2014). “Hospitalization for Dupuytren’s Disease: A French National Descriptive Analysis, 2002 to 2009.” Orthopaedics and Traumatology: Surgery and Research 100 (6). Elsevier Masson SAS: 589–92. (PDF)
• McMillan Catherine, Yeung Celine, Binhammer Paul. (2017). “Variation in Treatment Recommendations for Dupuytren Disease.” The Journal of Hand Surgery, no. Dd. Elsevier Inc. http://linkinghub.elsevier.com/retrieve/pii/S0363502316311418. (PDF)
• Povlsen Bo, Shields Adrian M, Bhabra Gev S. (2014). “Resource Utilisation Associated with Single Digit Dupuytren’s Contracture Treated with Either Surgery or Injection of Collagenase Clostridium Histolyticum.” Hand Surgery : An International Journal Devoted to Hand and Upper Limb Surgery and Related Research : Journal of the Asia-Pacific Federation of Societies for Surgery of the Hand 19 (2): 205–9. (PDF)
• Wiwanitkit Viroj. (2012). “Cost of Open Partial Fasciectomy, Needle Aponeurotomy, and Collagenase Injection for Dupuytren Contracture.” Journal of Hand Surgery 37 (2). Elsevier Inc.: 394. (PDF)